Keryx Biopharmaceuticals, Inc. Current Ratio 2010-2018 | KERX
Keryx Biopharmaceuticals, Inc. current ratio from 2010 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2018-09-30 | $0.13B | $0.06B | 2.21 |
| 2018-06-30 | $0.13B | $0.06B | 2.28 |
| 2018-03-31 | $0.12B | $0.05B | 2.66 |
| 2017-12-31 | $0.14B | $0.05B | 3.12 |
| 2017-09-30 | $0.17B | $0.04B | 4.46 |
| 2017-06-30 | $0.18B | $0.03B | 5.76 |
| 2017-03-31 | $0.12B | $0.02B | 5.39 |
| 2016-12-31 | $0.13B | $0.02B | 6.17 |
| 2016-09-30 | $0.16B | $0.02B | 8.75 |
| 2016-06-30 | $0.20B | $0.02B | 8.66 |
| 2016-03-31 | $0.22B | $0.07B | 3.14 |
| 2015-12-31 | $0.25B | $0.08B | 3.21 |
| 2015-09-30 | $0.15B | $0.03B | 4.83 |
| 2015-06-30 | $0.17B | $0.03B | 6.27 |
| 2015-03-31 | $0.20B | $0.04B | 5.52 |
| 2014-12-31 | $0.10B | $0.03B | 3.36 |
| 2014-09-30 | $0.12B | $0.03B | 4.34 |
| 2014-06-30 | $0.14B | $0.02B | 7.47 |
| 2014-03-31 | $0.16B | $0.02B | 9.55 |
| 2013-12-31 | $0.06B | $0.02B | 3.71 |
| 2013-09-30 | $0.07B | $0.02B | 4.34 |
| 2013-06-30 | $0.08B | $0.01B | 6.91 |
| 2013-03-31 | $0.09B | $0.01B | 10.29 |
| 2012-12-31 | $0.02B | $0.01B | 1.88 |
| 2012-09-30 | $0.02B | $0.01B | 2.71 |
| 2012-06-30 | $0.03B | $0.01B | 2.95 |
| 2012-03-31 | $0.03B | $0.01B | 3.24 |
| 2011-12-31 | $0.04B | $0.01B | 4.10 |
| 2011-09-30 | $0.05B | $0.01B | 4.84 |
| 2011-06-30 | $0.05B | $0.01B | 7.84 |
| 2011-03-31 | $0.02B | $0.01B | 3.53 |
| 2010-12-31 | $0.03B | $0.01B | 4.64 |
| 2010-09-30 | $0.04B | $0.01B | 4.49 |
| 2010-06-30 | $0.03B | $0.01B | 5.17 |
| 2010-03-31 | $0.03B | $0.01B | 5.76 |
| 2009-12-31 | $0.04B | $0.01B | 5.89 |
| 2009-09-30 | $0.04B | $0.01B | 5.40 |
| 2009-06-30 | $0.01B | $0.01B | 2.72 |
| 2009-03-31 | $0.02B | $0.01B | 2.73 |
